Investing in biotech companies, especially relatively small ones, can be a double-edged sword. Their shares often soar on strong clinical trial or regulatory news,...
Scott McTominay and Billy Gilmour may not be immediate starters at Napoli, but Stephen Kasiewicz suggests Antonio Conte has multiple options to deploy the...